Your browser doesn't support javascript.
loading
A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas.
Vitfell-Rasmussen, Joanna; Judson, Ian; Safwat, Akmal; Jones, Robin L; Rossen, Philip Blach; Lind-Hansen, Maja; Knoblauch, Poul; Krarup-Hansen, Anders.
  • Vitfell-Rasmussen J; Herlev University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.
  • Judson I; The Institute of Cancer Research: Royal Cancer Hospital, 123 Old Brompton Road, London SW7 3RP, UK.
  • Safwat A; Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark.
  • Jones RL; The Institute of Cancer Research: Royal Cancer Hospital, 123 Old Brompton Road, London SW7 3RP, UK.
  • Rossen PB; Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark.
  • Lind-Hansen M; Herlev University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.
  • Knoblauch P; Onxeo, c/o Symbion, Fruebjergvej 3, 2100 København, Denmark.
  • Krarup-Hansen A; Herlev University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.
Sarcoma ; 2016: 2090271, 2016.
Article en En | MEDLINE | ID: mdl-27403082